Best of the Week
Most Popular
1. Investing in a Bubble Mania Stock Market Trending Towards Financial Crisis 2.0 CRASH! - 9th Sep 21
2.Tech Stocks Bubble Valuations 2000 vs 2021 - 25th Sep 21
3.Stock Market FOMO Going into Crash Season - 8th Oct 21
4.Stock Market FOMO Hits September Brick Wall - Evergrande China's Lehman's Moment - 22nd Sep 21
5.Crypto Bubble BURSTS! BTC, ETH, XRP CRASH! NiceHash Seizes Funds on Account Halting ALL Withdrawals! - 19th May 21
6.How to Protect Your Self From a Stock Market CRASH / Bear Market? - 14th Oct 21
7.AI Stocks Portfolio Buying and Selling Levels Going Into Market Correction - 11th Oct 21
8.Why Silver Price Could Crash by 20%! - 5th Oct 21
9.Powell: Inflation Might Not Be Transitory, After All - 3rd Oct 21
10.Global Stock Markets Topped 60 Days Before the US Stocks Peaked - 23rd Sep 21
Last 7 days
Chinese Tech Stocks CCP Paranoia, VIES - Variable Interest Entities - 19th Oct 21
Inflation Peaked Again, Right? - 19th Oct 21
Gold Stocks Bouncing Hard - 19th Oct 21
Stock Market New Intermediate Bottom Forming? - 19th Oct 21
Beware, Gold Bulls — That’s the Beginning of the End - 18th Oct 21
Gold Price Flag Suggests A Big Rally May Start Soon - 18th Oct 21
Inflation Or Deflation – End Result Is Still Depression - 18th Oct 21
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector - 18th Oct 21
US Economy and Stock Market Addicted to Deficit Spending - 17th Oct 21
The Gold Price And Inflation - 17th Oct 21
Went Long the Crude Oil? Beware of the Headwinds Ahead… - 17th Oct 21
Watch These Next-gen Cloud Computing Stocks - 17th Oct 21
Overclockers UK Custom Built PC 1 YEAR Use Review Verdict - Does it Still Work? - 16th Oct 21
Altonville Mine Tours Maze at Alton Towers Scarefest 2021 - 16th Oct 21
How to Protect Your Self From a Stock Market CRASH / Bear Market? - 14th Oct 21
The Only way to Crush Inflation (not stocks) - 14th Oct 21
Why "Losses Are the Norm" in the Stock Market - 14th Oct 21
Sub Species Castle Maze at Alton Towers Scarefest 2021 - 14th Oct 21
Which Wallet is Best for Storing NFTs? - 14th Oct 21
Ailing UK Pound Has Global Effects - 14th Oct 21
How to Get 6 Years Life Out of Your Overclocked PC System, Optimum GPU, CPU and MB Performance - 13th Oct 21
The Demand Shock of 2022 - 12th Oct 21
4 Reasons Why NFTs Could Be The Future - 12th Oct 21
Crimex Silver: Murder Most Foul - 12th Oct 21
Bitcoin Rockets In Preparation For Liftoff To $100,000 - 12th Oct 21
INTEL Tech Stock to the MOON! INTC 2000 vs 2021 Market Bubble WARNING - 11th Oct 21
AI Stocks Portfolio Buying and Selling Levels Going Into Market Correction - 11th Oct 21
Stock Market Wall of Worry Meets NFPs - 11th Oct 21
Stock Market Intermediate Correction Continues - 11th Oct 21
China / US Stock Markets Divergence - 10th Oct 21
Can US Save Taiwan From China? Taiwan Strait Naval Battle - PLA vs 7th Fleet War Game Simulation - 10th Oct 21
Gold Price Outlook: The Inflation Chasm Between Europe and the US - 10th Oct 21
US Real Estate ETFs React To Rising Housing Market Mortgage Interest Rates - 10th Oct 21
US China War over Taiwan Simulation 2021, Invasion Forecast - Who Will Win? - 9th Oct 21
When Will the Fed Taper? - 9th Oct 21
Dancing with Ghouls and Ghosts at Alton Towers Scarefest 2021 - 9th Oct 21
Stock Market FOMO Going into Crash Season - 8th Oct 21
Scan Computers - Custom Build PC 6 Months Later, Reliability, Issues, Quality of Tech Support Review - 8th Oct 21
Gold and Silver: Your Financial Main Battle Tanks - 8th Oct 21
How to handle the “Twin Crises” Evergrande and Debt Ceiling Threatening Stocks - 8th Oct 21
Why a Peak in US Home Prices May Be Approaching - 8th Oct 21
Alton Towers Scarefest is BACK! Post Pandemic Frights Begin, What it's Like to Enter Scarefest 2021 - 8th Oct 21
AJ Bell vs II Interactive Investor - Which Platform is Best for Buying US FAANG Stocks UK Investing - 7th Oct 21
Gold: Evergrande Investors' Savior - 7th Oct 21
Here's What Really Sets Interest Rates (Not Central Banks) - 7th Oct 21

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Wednesday, February 27, 2013

The Picks and Shovels of Biotech Investing / Companies / BioTech

By: Investment_U

Marc Lichtenfeld writes: Yesterday marked the 184th birthday of an iconic American businessman – Levi Strauss

My wife worked for Levi Strauss & Co. many years ago. They were a terrific company, with a strong commitment to product quality, their employees and their community. I was so impressed that I remain loyal and almost exclusively buy Levi’s when I need a pair of jeans.

Read full article... Read full article...

 


Companies

Wednesday, January 16, 2013

BioTech Bull Market's Next 1,000%-Plus Move Starts Now / Companies / BioTech

By: DailyWealth

Dr. Steve Sjuggerud writes: Biotech stocks have an incredible history of delivering quadruple-digit runs about once a decade...

It's stunning, really. In the late 1980s, biotech stocks took off, returning 3,246% in just a couple years. In the late 1990s, biotech stocks took off again, returning 1,523% in an even shorter period of time.

Read full article... Read full article...

 


Companies

Thursday, December 13, 2012

The Next Profit Breakthrough: Synthetic Biology / Companies / BioTech

By: Money_Morning

Michael A. Robinson writes: Drug, chemical, and biofuel firms are relying more than ever on artificial fragments of DNA to invent new products. It's called synthetic biology.

For example, teams all over the world are now in their labs looking to create novel biotech compounds or drugs by inserting synthetic DNA into cells, either living or artificial. They're also growing new microorganisms that yield biofuels to be used in lieu of oil.

Read full article... Read full article...

 


Companies

Tuesday, December 11, 2012

Cancer, Breaking Down a Biotech Winner / Companies / BioTech

By: Alex_Daley

Traditional cancer treatment options are little more than a crude mix of "slash, burn, and poison" â �that is surgery, radiation, and chemotherapy. There are radical new treatments in labs and trials all over the world that promise to throw out this trifecta; no other disease has received more of the research interest and funding that have defined modern biotechnology over the past three decades.

Read full article... Read full article...

 


Companies

Thursday, November 15, 2012

Biotech Stocks to Buy Now / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleDon Miller writes: If you're looking to hit a home run over the next 12 months, your best bet for stocks to buy now is biotechnology companies - especially those focused on cancer research.

Here's why: biotech stocks have been in a stealth bull market in 2012.

Read full article... Read full article...

 


Companies

Monday, October 22, 2012

Adult Stem Cells: Investors can Cash in on the New Fountain of Youth / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: It's flat-out amazing how fast the science of adult stem cells is moving.

Just last week, I told you about two scientists who won the 2012 Nobel Prize in Medicine for creating this field.

Read full article... Read full article...

 


Companies

Friday, October 19, 2012

Adult Stem Cell Miracle Will Generate Investor Profits / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: Recently, I was in a meeting at our headquarters in Baltimore, explaining to my editor how excited I was to tell readers about a whole new range of adult stem-cell breakthroughs.

This field of medicine is so exciting it was easy to show how these adult stem cell lines will someday play a vital role in the future of the human race.

Read full article... Read full article...

 


Companies

Friday, October 12, 2012

Forecasting Explosive Biotech Growth, Investor Patience / Companies / BioTech

By: TLSReport

Best Financial Markets Analysis ArticleThe myth of technology, whether for smartphones or cancer treatments, is that the next big thing appears suddenly and magically. Casey Research Analyst Alex Daley sets the record straight in this exclusive interview with The Life Sciences Report. While the science of genetic medicine has accelerated the process of turning magical thinking into practical medicine, Daley cautions investors in biotech and medical device companies to be patient, and names companies with innovative technologies poised for explosive growth.

The Life Sciences Report: At Casey Research's "Navigating the Politicized Economy" summit, you talked about the difference between the speed of science and the speed of technology, and how quickly the time to market and cost of products in the life sciences space is decreasing. Can you provide some examples?

Read full article... Read full article...

 


Companies

Monday, October 01, 2012

New "Protein Chips" Could Save Your Life and Make You Money / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: Ever since some wag came up with the term "Silicon Valley" in the 1970s, investors have thought of semiconductors as the brains behind computers.

That was then. This is now...

Today, semiconductors are about a lot more than computers.

Read full article... Read full article...

 


Companies

Friday, August 24, 2012

The Key to Huge Biotech Profits / Companies / BioTech

By: TLSReport

 

Best Financial Markets Analysis ArticleChen Lin is a well-known expert junior metals and energy investor, but he has found compelling reasons to diversify into biotechnology. In this exclusive interview with The Life Sciences Report, Lin meshes common sense and personal experience with his trademark brand of aggressive investment savvy to identify three life sciences stocks that could be huge gainers for investors.

The Life Sciences Report: Chen, we know you as a natural resource investor. How long have you been a life sciences investor? Is this a new category for you?

 

Read full article... Read full article...

 


Companies

Monday, August 20, 2012

These Biotech Firms Will Literally Change the World / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: The biotech industry is getting ready to transform the human race as we know it.

It will help us cure cancer, rid us of the scourge of Alzheimer's, and make 100-year life spans routine. Not only that, but we will lead much healthier and more intelligent lives as a result.

Read full article... Read full article...

 


Companies

Monday, August 13, 2012

"Bionic Eyes" Could Make Blindness a Thing of the Past / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: Just last week I told you the day of bionic humans is at hand.

Some of you were excited by the possibilities. Take Matt:

"As someone who has bounced back from a severe head injury 25 years ago to do things the brain injury rehab team told me would simply not be possible - complete my bachelor's degree as well as a master's, get married, and subsequently raise a son on my own as a single parent, etc. - I am especially excited about the possibilities at the juncture of neurological research, computing technology, and prosthetics. I will be overjoyed when the day comes that I can once again use both my hands to type 100 words/minute with few to no mistakes, like I could when I first learned to type on an electric typewriter, nearly 40 years ago."

Read full article... Read full article...

 


Companies

Thursday, July 26, 2012

Man-Made Proteins Put a New Twist on Evolution / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: Man-made proteins. You may have never heard of them, but you will.

They are set to become huge change agents in the high-tech world of the very near future.

Some of you may have already heard the recent news that doctors believe they can use these compounds to help fight the flu.

Read full article... Read full article...

 


Companies

Wednesday, June 13, 2012

How to Spot the Next Hot Biotech Stock / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleKeith Fitz-Gerald writes: It's not enough to understand long- term trends, today's investors need to have the ability to move quickly, especially when it comes to biotech stocks.

But here is what you need to know about biotech stocks: none of them are created equal.

Read full article... Read full article...

 


Companies

Wednesday, May 23, 2012

Biotechnology Pushes the Boundaries of Life, It's Like Having a "Fountain of Youth" in a Bottle / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleMichael A. Robinson writes: Most people will do just about anything to avoid getting a virus.

And yet...There is a microbe that just about everyone will want to invade their bodies.

It's a new "bug" that can actually make you young again.

Read full article... Read full article...

 


Companies

Wednesday, May 16, 2012

How to Ride the Surge in Biotech Mergers & Acquisitions / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleDon Miller writes: Innovations in biotechnology are evolving at the speed of light.

In fact, astonishing advancements in biotech have transformed the way we practice medicine. Leading-edge biotech products and breakthroughs are literally saving thousands of lives every day.

Read full article... Read full article...

 


Companies

Friday, April 27, 2012

How You can Double Your Money in Days Trading Biotech Stocks / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleWilliam Patalon III writes: At the beginning of May 2011, OXiGENE Inc. (Nasdaq: OXGN) was a relatively unremarkable biotech stock. It was trading at less than $2 a share.

You might even say that OXiGENE was deeply troubled.

Read full article... Read full article...

 


Companies

Monday, April 09, 2012

Biotech Stocks: How to Invest in the Buyout Binge / Companies / BioTech

By: Money_Morning

Best Financial Markets Analysis ArticleWilliam Patalon III writes: Big drugmakers are scrambling.

Right now, some of their most-lucrative blockbuster drugs are coming "off patent" - meaning they face the loss of $170 billion in annual sales.

But I'm going to let you in on a secret that Wall Street investment pros hope the little guy never learns: The very same problem that has Big Pharma execs wringing their hands even as you read this is also creating one of the biggest profit opportunities we've seen in years.

Read full article... Read full article...

 


Page << | 1 | 5 | 6 | 7 | 8 | >>